Fifth Third Wealth Advisors LLC Purchases 2,002 Shares of Danaher Co. (NYSE:DHR)

Fifth Third Wealth Advisors LLC boosted its stake in shares of Danaher Co. (NYSE:DHR) by 55.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,586 shares of the conglomerate’s stock after purchasing an additional 2,002 shares during the quarter. Fifth Third Wealth Advisors LLC’s holdings in Danaher were worth $1,396,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Cape Investment Advisory Inc. acquired a new position in shares of Danaher in the 4th quarter valued at $25,000. Tsfg LLC raised its stake in shares of Danaher by 733.3% in the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after buying an additional 88 shares in the last quarter. CarsonAllaria Wealth Management Ltd. acquired a new position in shares of Danaher in the 2nd quarter valued at $25,000. Wetzel Investment Advisors Inc. acquired a new position in shares of Danaher in the 4th quarter valued at $29,000. Finally, Redmont Wealth Advisors LLC acquired a new position in shares of Danaher in the 1st quarter valued at $30,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 9,600 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total transaction of $2,641,536.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $5,566,486.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Brian W. Ellis sold 9,600 shares of Danaher stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $5,566,486.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Linda Filler sold 3,928 shares of Danaher stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $279.50, for a total transaction of $1,097,876.00. Following the completion of the sale, the director now owns 41,149 shares in the company, valued at $11,501,145.50. The disclosure for this sale can be found here. In the last three months, insiders have sold 38,707 shares of company stock worth $10,786,944. Company insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on DHR. TD Cowen increased their target price on shares of Danaher from $290.00 to $310.00 and gave the stock a “buy” rating in a research report on Wednesday, July 24th. Royal Bank of Canada increased their target price on shares of Danaher from $297.00 to $300.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Bank of America increased their target price on shares of Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 24th. Citigroup increased their price objective on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Finally, Stifel Nicolaus increased their price objective on shares of Danaher from $235.00 to $250.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. Six analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $276.88.

Danaher Trading Down 0.2 %

Danaher stock traded down $0.51 during midday trading on Wednesday, hitting $271.15. 1,455,079 shares of the stock were exchanged, compared to its average volume of 2,837,010. The company has a fifty day simple moving average of $258.16 and a two-hundred day simple moving average of $254.08. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $281.70. The stock has a market capitalization of $200.84 billion, a PE ratio of 45.96, a P/E/G ratio of 4.62 and a beta of 0.83. The company has a quick ratio of 1.04, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the firm earned $2.05 EPS. Danaher’s quarterly revenue was down 2.9% compared to the same quarter last year. Equities research analysts anticipate that Danaher Co. will post 7.59 EPS for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.